A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|32|5131-5140

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.32, 2012-11, pp. : 5131-5140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antipsychotic-like Effects of Cannabidiol and Rimonabant: Systematic Review of Animal and Human Studies

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 5141-5155

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Protective Effects of Cannabidiol on Neuroanatomical Alterations in Cannabis Users and Psychosis: A Critical Review

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 4897-4905

Bentham Science Publishers

Access to resources Recommend Favorite

A Critical Review of Atypical Antipsychotic Utilization: Comparing Monotherapy with Polypharmacy and Augmentation

By  

Current Medicinal Chemistry, Vol. 11, Iss. 3, 2004-02 ,pp. : 313-327

Bentham Science Publishers

Access to resources Recommend Favorite

Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 4960-4965

Bentham Science Publishers

Access to resources Recommend Favorite

Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review

By  

Current Neuropharmacology, Vol. 13, Iss. 4, 2015-01 ,pp. : 422-434

Bentham Science Publishers

Access to resources Recommend Favorite